Biosensors gets buyout offer from Citic Private Equity
BIOSENSORS International Group said on Wednesday it has received an offer from Citic Private Equity Funds Management Co for the proposed amalgamation of the group with its substantial shareholder, CB Medical Holdings.
Biosensors' board of directors is currently reviewing the offer, which was received on Oct 23, it added. But it stressed that discussions are on-going, so there is no certainty or assurance that these discussions will result in any transaction.
The China-based fund Citi Private Equity had acquired the stake in Biosensors last year from Shandong Weigao Group Medical Polymer. Talks that Citic was considering a buyout of Biosensors surfaced as early as last year. CB Medical is owned by Citic Private Equity.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Emerging-market optimism dashed by Fed as currencies, bonds sink
LHN warns H1 2024 net profit could decline by 28.6%
iPhone maker Hon Hai’s April sales rise 19% in positive signal
Worsening weather is igniting a US$25 billion market
TikTok tells advertisers: ‘We are not backing down’
EV automakers get reprieve in US tax credit rules